Literature DB >> 7838932

Platelet intracellular calcium in patients with recurrent affective disorders.

R A Bothwell1, D Eccleston, E Marshall.   

Abstract

Forty-four subjects with a history of a major recurrent affective disorder in remission and who were either on no medication or taking a single dose of psychotropic medication were conscripted together with matched controls. The fluorescent indicator fura 2 was used to measure intracellular calcium in platelets and estimations were made of total serum and ionised calcium as well as of whole blood serotonin. Intracellular calcium was measured in the resting state as well as after stimulation with thrombin, platelet activating factor and serotonin. No significant differences were found between the 17 subjects with a diagnosis of bipolar disorder or the 27 subjects with recurrent unipolar depression and their matched controls. Intracellular calcium measures were significantly higher in the lithium treated group after stimulation with 5HT, whereas the subjects taking tricyclic antidepressants did not differ significantly from their controls on any measure. Serum calcium was found to be significantly higher in those subjects taking lithium. These findings suggest that the measurement of intracellular calcium is not a useful trait marker in affective disorders. Lithium appears to enhance the 5HT induced rise of intracellular calcium.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7838932     DOI: 10.1007/bf02244862

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  62 in total

1.  A study of cerebrospinal fluid calcium and magnesium in depression.

Authors:  A H Hakim; B S Bomb; S K Pandey; S V Singh
Journal:  J Assoc Physicians India       Date:  1975-05

2.  The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects.

Authors:  H K Manji; J K Hsiao; E D Risby; J Oliver; M V Rudorfer; W Z Potter
Journal:  Arch Gen Psychiatry       Date:  1991-06

3.  The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors.

Authors:  P W Glue; P J Cowen; D J Nutt; T Kolakowska; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy.

Authors:  P Erne; P Bolli; E Bürgisser; F R Bühler
Journal:  N Engl J Med       Date:  1984-04-26       Impact factor: 91.245

5.  RBC membrane adenosine triphosphatase activities in patients with major affective disorders.

Authors:  M Linnoila; E MacDonald; M Reinila; A Leroy; D R Rubinow; F K Goodwin
Journal:  Arch Gen Psychiatry       Date:  1983-09

6.  Calcium metabolism and mental disorder.

Authors:  J L Crammer
Journal:  Psychol Med       Date:  1977-11       Impact factor: 7.723

7.  Lithium inhibition of protein kinase C activation-induced serotonin release.

Authors:  H Y Wang; E Friedman
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania.

Authors:  H Y Meltzer; B Umberkoman-Wiita; A Robertson; B J Tricou; M Lowy; R Perline
Journal:  Arch Gen Psychiatry       Date:  1984-04

9.  CSF calcium: clinical correlates in affective illness and schizophrenia.

Authors:  D C Jimerson; R M Post; J S Carman; D P van Kammen; J H Wood; F K Goodwin; W E Bunney
Journal:  Biol Psychiatry       Date:  1979-02       Impact factor: 13.382

10.  Kinetic characterization and substrate requirement for the Ca2+ uptake system in platelet membrane.

Authors:  M A Javors; C L Bowden; D H Ross
Journal:  Biochim Biophys Acta       Date:  1982-10-07
View more
  1 in total

1.  Serotonin-induced decrease of intracellular Ca(2+) release in platelets of bulimic patients normalizes during treatment.

Authors:  Lars Wöckel; Florian Daniel Zepf; Sabrina Koch; Anikó-Eva Meyer-Keitel; Martin H Schmidt
Journal:  J Neural Transm (Vienna)       Date:  2008-12-10       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.